Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-59.40	15.23	37.51
Graham Fair Price	48.26	14.74	9.94
PEG	-80.93	0.12	-0.62
Price/Book	-11.47	0.74	0.83
Price/Cash Flow	68.62	-35.01	-111.56
Prices/Earnings	-58.68	15.75	38.11
Price/Sales	-6.93	2.34	2.51
Price/FCF	68.62	-35.01	-111.56
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	6.20	0.34	0.32
Operating Margin	20.30	0.12	0.10
ROA	113.81	< 0.005	< 0.005
ROE	< 0.005	0.01	114.27
ROIC	< 0.005	0.02	54.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.19	0.39	-51.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.15	0.16	5.01
EPS QOQ	-0.62	1.33	116.67
FCF QOQ	-1.28	-1.86	-45.29
Revenue QOQ	0.04	-0.04	-10.29
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.46	11.85	-18.05
Days Sales Outstanding (DSO)	88.85	90.51	1.86
Inventory Turnover	6.22	7.59	22.03
Debt/Capitalization	0.40	0.35	-13.02
Quick Ratio	0.82	0.93	13.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	28.34	28.71	1.28
Cash	0.30	0.90	199.23
Capex	-1.70	-0.81	52.58
Free Cash Flow	-0.21	-0.61	-185.77
Revenue	9.40	9.06	-3.65
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.91	1.01	11.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.60	6.35	-61.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating